Toggle Menu
Stocknear
ctrl
K
/
Search
Popular
KO
Coca Cola Company
Stock
TSLA
Tesla Inc
Stock
AMD
Advanced Micro Devices
Stock
SPY
SPDR S&P 500 ETF Trust
ETF
NVDA
Nvidia
Stock
Login
Watchlist
Price Alert
MEDIROM Healthcare Techno...
(MRM)
NASDAQ: MRM · Real-Time Price · USD
1.51
0.00
(0.00%)
At close:
Jun 03, 2025, 3:55 PM
1.51
0.00%
After-hours:
Jun 03, 2025, 07:22 PM EDT
Overview
Financials
Statistics
Metrics
Dark Pool
Options
Insider
Dividends
History
Profile
Overview
Franchise
Other revenues
Other franchise revenues
Royalty income
Staffing service revenue
Sublease revenue
MEDIROM Healthcare Revenue Breakdown
Period Ending
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Franchise Revenue
316.65M
523.33M
645.73M
43.97M
175.44M
Franchise Revenue Growth
-39.49%
-18.96%
+1368.74%
-74.94%
n/a
Other revenues Revenue
160.63M
200.4M
427.03M
247.35M
n/a
Other revenues Revenue Growth
-19.85%
-53.07%
+72.64%
n/a
n/a
Other franchise revenues Revenue
179.35M
181.76M
630.23M
209.85M
n/a
Other franchise revenues Revenue Growth
-1.32%
-71.16%
+200.33%
n/a
n/a
Royalty income Revenue
156.32M
181.42M
403.17M
263.96M
n/a
Royalty income Revenue Growth
-13.83%
-55.00%
+52.74%
n/a
n/a
Staffing service revenue Revenue
76.84M
136.57M
86.97M
437.98M
n/a
Staffing service revenue Revenue Growth
-43.74%
+57.02%
-80.14%
n/a
n/a
Sublease revenue Revenue
308.31M
364.37M
411.7M
n/a
n/a
Sublease revenue Revenue Growth
-15.38%
-11.50%
n/a
n/a
n/a
Operating Expense Breakdown
Period Ending
Dec 31, 2024
Jun 30, 2024
Dec 31, 2023
Jun 30, 2023
Dec 31, 2022
Jun 30, 2022
Dec 31, 2021
Jun 30, 2021
Dec 31, 2020
Jun 30, 2020
Dec 31, 2019
Jun 30, 2019
Dec 31, 2018
Jun 30, 2018
Selling, General, and Administrative Revenue
1.03B
1.21B
971.23M
989.22M
835.99M
484.75M
485.01M
420.38M
273.59M
260.68M
460.14M
411.72M
421.41M
421.41M
Selling, General, and Administrative Revenue Growth
-15.25%
+24.92%
-1.82%
+18.33%
+72.46%
-0.05%
+15.38%
+53.66%
+4.95%
-43.35%
+11.76%
-2.30%
0.00%
n/a
Research and Development Revenue
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Research and Development Revenue Growth
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Add to Watchlist
✕